Evidence map›Paper›PMID 39429564›Full record

ArticleQuantitative imaging in medicine and surgery2024

The relationship between sarcopenia and metabolic parameters of

Xin Xu, Jin Zhou, Xiaodong Yao, Shibiao Sang, Jihui Li, Bo Wang, Yi Yang, Bin Zhang, Shengming Deng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Prognostic significance of liver-to-muscle FDG uptake ratio and ınflammatory biomarkers in small cell lung cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  3. Role of muscle glucometabolism derived fromQuantitative imaging in medicine and surgery · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xin Xu *Department of Nuclear Medicine, the First Affiliated Hospital of Soochow University, Suzhou, China.
Jin Zhou *Department of Nuclear Medicine, Shuyang Hospital Affiliated to Medical College of Yangzhou University, Suqian, China.
Xiaodong Yao *Department of Medical Cosmetology, Department of Dermatology, Affiliated Hospital of Nantong University, Nantong, China.
Shibiao SangDepartment of Nuclear Medicine, the First Affiliated Hospital of Soochow University, Suzhou, China.
Jihui LiDepartment of Nuclear Medicine, the First Affiliated Hospital of Soochow University, Suzhou, China.
Bo WangDepartment of Nuclear Medicine, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, China.
Yi YangDepartment of Nuclear Medicine, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, China.
Bin ZhangDepartment of Nuclear Medicine, the First Affiliated Hospital of Soochow University, Suzhou, China.
Shengming DengDepartment of Nuclear Medicine, the First Affiliated Hospital of Soochow University, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with lung cancer face a heightened risk of developing sarcopenia. Despite this known risk, the impact of sarcopenia on the long-term prognosis of lung cancer patients, specifically concerning progression-free survival (PFS) and overall survival (OS), remains unclear. The primary objective of our study was to examine the correlation between metabolic parameters derived from Methods: In this retrospective cross-sectional study, we analyzed 187 NSCLC patients who underwent Results: Our analysis identified gender, body mass index (BMI), psoas Hounsfield unit (HU), and maximum standardized uptake value of the psoas major muscle (SUV Conclusions: Our findings indicated an inverse relationship between SUV

Indexed as

Non-small cell lung cancer (NSCLC)positron emission tomography/computed tomography (PET/CT)prognosisprogrammed death ligand-1 (PD-L1)sarcopenia

Identifiers

PMID39429564
PMCPMC11485386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.